Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury

GLIA

Volumn 30, Issue 2, 2000, Pages 199-208

  Jaworski, Diane M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

BEHAB; Brevican; CNS; Extracellular matrix; MMP; Reactive gliosis; TIMP

Indexed keywords

EID: 0034076682     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-1136(200004)30:2<199::aid-glia9>3.0.co;2-%23     Document Type: Article

References (69)

1. Amberger VR, Avellana-Adalid V, Hensel T, Evercooren B, Schwab ME. 1997. Oligodendrocyte-type 2 progenitors use a metalloendoprotease to spread and migrate on CNS myelin. Eur J Neurosci 9:151-162.
2. Baker AH, Zaltsman AB, George SJ, Newby AC. 1998. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. J Clin Invest 101:1478-1487.
3. Barasch J, Yang J, Qiao J, Tempst P, Erdjument-Bromage H, Leung W, Oliver JA. 1999. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest 103:1299-1307.
4. Barker RA, Dunnett SB, Faissner A, Fawcett JW. 1996. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol 141:79-93.
5. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. 1994. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 38:365-375.
6. Beliën ATJ, Paganetti PA, Schwab ME. 1999. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol 144:373-384.
7. Benfey M, Aguayo AJ. 1982. Extensive elongation of axons from rat brain into peripheral nerve grafts. Nature 296:150-152.
8. Bertaux B, Hornbeck W, Eisen AZ, Dubertret L. 1991. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97:679-685.
9. Bignami A, Dahl D. 1976. The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFA) in mammalian and submammalian vertebrates. Neuropathol Appl Neurobiol 2:99-110.
10. Brodkey JA, Laywell ED, O'Brien TF, Faissner A, Steffansson K, Dorries HU, Schachner M, Steindler DA. 1995. Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg 82:106-112.
11. Bungno M, Witek B, Bereta J, Bereta M, Edwards DR, Kordula T. 1999. Reprogramming of Timp-1 and Timp-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett 448:9-14.
12. Chesler L, Golde DW, Bersch N, Johnson MD. 1995. Metalloproteinase inhibitor and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 86:4506-4515.
13. Clemente, CD. 1995. Structural regeneration in the mammalian central nervous system and the role of neuroglia and connective tissue. In: Windle WF, editor. Regeneration in the central nervous system. Springfield, IL: Thomas. p 147-161.
14. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. 1994. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83:140-147.
15. David S, Aguayo AJ. 1981. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 214:931-933.
16. Davies SJA, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. 1997. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680-683.
17. Del Bigio MR, Tchelingerian JL, Jacque CM. 1999. Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells. Neuropathol Appl Neurobiol 25:54-62.
18. DiProspero NA, Meiners S, Geller HM. 1997. Inflammatory cytokines interact to modulate extracellular matrix and astrocytic support of neurite outgrowth. Exp Neurol 148:628-639.
19. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G, Reynolds JJ. 1985. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318:66-69.
20. Dollery CM, McEwan JR, Wang M, Sang QA, Liu YE, Shi YE. 1999. Timp-4 is regulated by vascular injury in rats. Circ Res 84:498-504.
21. Edwards DR. 1999. The tissue inhibitors of metalloproteinases (TIMPs). In: Clendennin NJ, Applet K, editors. Matrix metalloproteinase inhibitors in cancer therapy. Totawa, NJ: Humana Press.
22. Eng LF, Ghirnikar RS. 1994. GFAP and astrogliosis. Brain Pathol 4:229-237.
23. Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R. 1999. Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 211: 238-254.
24. Fawcett JW. 1997. Astrocytic and neuronal factors affecting axon regeneration in the damaged central nervous system. Cell Tissue Res 290:371-377.
25. Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K, Nagase H. 1995. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 6:255-263.
26. Frederiksen F, McKay RDG. 1988. Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J Neurosci 8:1144-1151.
27. Friedmann I, Faber-Elman A, Yoles E, Schwartz M. 1999. Injury-induced gelatinase and thrombin-like activities in regenerating and nonregenerating nervous systems. FASEB J 13:533-543.
28. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL, Orr EC, Clark SC. 1985. Molecular characterization and expression of the gene encoding human ervthroid-potentiating activity. Nature 315: 768-771.
29. Geisert Jr. EE, Bidanset DJ, del Mar N, Robson JA. 1996. Up-regulation of a keratan sulfate proteoglycan following cortical injury in neonatal rats. Int J Dev Neurosci 14:257-267.
30. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements JM, Crimmin M, Davidson AH, Drummond AH, Galloway WA, Gilbert R, et al. 1995. Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol 57:774-777.
31. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. 1992. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298:29-32.
32. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. 1994. Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2). J Cell Sci 107:2373-2379.
33. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E. 1994. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302:527-534.
34. Hockfield S, McKay R. 1985. Identification of major cell classes in the developing mammalian nervous system. J Neurosci 5:3310-3328.
35. Höke A, Sliver J. 1996. Proteoglycans and other repulsive molecules in glial boundaries during development and regeneration of the nervous system. Prog Brain Res 108:149-163.
36. Jaworski DM, Kelly GM, Hockfield S. 1994. BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan binding proteins that is restricted to brain. J Cell Biol 125:495-509.
37. Jaworski DM, Kelly GM, Hockfield S. 1999. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican. Exp Neurol 157:327-337.
38. La Fleur M, Underwood JL, Rappolee DA, Werb Z. 1996. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184:2311-2326.
39. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. 1994. Tissue inhibitor of metalloproteinases-3 (Timp-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269:9352-9360.
40. LeVine JM. 1994. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J Neurosci 14:4716-4730.
41. Lin RCS, Matesic DF, Marvin M, McKay RDG, Brüstle O. 1995. Re-expression of the intermediate filament nestin in reactive astrocytes. Neurobiol Dis 2:79-85.
42. Machida CM, Rodland KD, Matrisian L, Magun BE, Ciment G. 1989. NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC 12 cells. Neuron 2:1587-1596.
43. Mansour H, Asher R, Dahl D, Labkovsky B, Perides G, Bignami A. 1990. Permissive and non-permissive reactive astrocytes: immunofluorescence study with antibodies to the glial hyaluronate-binding protein. J Neurosci Res 25:300-311.
44. Monard D. 1988. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci 11:541-544.
45. Muir D. 1994. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 210:243-252.
46. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. 1993. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 157:351-358.
47. Nagase H. 1997. Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
48. Nordstrom LA, Lochner J, Yeung W, Ciment G. 1995. The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae. Mol Cell Neurosci 6:56-68.
49. Norton WT. 1999. Cell reactions following acute brain injury: a review. Neurochem Res 24:213-218.
50. Okada A, Garnier JM, Vicaire S, Basset P. 1994. Cloning of the cDNA encoding rat tissue inhibitor of metalloproteinase 1 (TIMP-1), amino acid comparison with other TIMPs, and gene expression in rat tissues. Gene 147:301-302.
51. Puchala E, Windle WF. 1977. The possibility of structural and functional restitution after spinal cord injury. A review. Exp Neurol 55:1-42.
52. Raivich G, Bohatschek M, Kloss CUA, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 30:77-105.
53. Ramon y Cajal, S. 1928. Degeneration and regeneration of the nervous system. New York: Hafner.
54. Reier PJ, Houle JD. 1988. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. In: Waxman SG, editor. Advances in neurology: functional recovery in neurological disease. New York: Raven. p 87-138.
55. Rivera S, Tremblay E, Timsit S, Canals O, Ben-Ari Y, Khrestchatisky M. 1997. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J Neurosci 17:4223-4235.
56. Rosenberg GA, Estrada EY, Dencoff JE. 1998. Matrix metalloproteinases and TIMPs are associated with the blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189-2195.
57. Rusnati M, Presta M. 1996. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int J Clin Lab Res 26:15-23.
58. Santoro M, Battaglia C, Zhang L, Carlomangno F, Martelli ML, Salvatore D, Fusco A. 1994. Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. Exp Cell Res 213:398-403.
59. Shaw G, Osborn M, Weber K. 1986. Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments. Eur J Cell Biol 42:1-9.
60. Snyder SE, Li J, Schauwecker PE, McNeill TH, Salton SR. 1996. Comparison of RPTP zeta/beta, phosphacan, and trkB mRNA expression in the developing and adult rat nervous system and induction of RPTP zeta/beta and phosphacan mRNA following brain injury. Mol Brain Res 40:79-96.
61. Stetler-Stevenson WG, Bersch N, Golde DW. 1992. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett 296:231-234.
62. Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D. 1996. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 15:177-186.
63. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA. 1996. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases. J Biol Chem 271:10079-10086.
64. Wu I, Moses MA. 1998. Molecular cloning and expression analysis of the cDNA encoding rat tissue inhibitor of metalloproteinase-4. Matrix Biol 16:339-342.
65. Yamada H, Fredette B, Shitara K, Hagihara K, Miura R, Ranscht B, Stallcup WB, Yamaguchi Y. 1997. The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons. J Neurosci 17:7784-7795.
66. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75-80.
67. Zhang JW, Deb S, Gottschall PE. 1998a. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci 10:3358-3368.
68. Zhang H, Kelly G, Zerillo C, Jaworski DM, Hockfield S. 1998b. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J Neurosci 18:2370-2376.
69. Zuo J, Ferguson TA, Hernandez YJ, Stetler-Stevenson WG, Muir D. 1998. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 18:5203-5211.